Invention Grant
![Triazolo[4,5-d] pyramidine derivatives and their use as purine receptor antagonists](/docs/US/2022-10-11/US11466019B2/abs.jpg.600x600.jpg)
- Patent Title: Triazolo[4,5-d] pyramidine derivatives and their use as purine receptor antagonists
-
Application No.: US17088325Application Date: 2020-11-03
-
Publication No.: US11466019B2Publication Date: 2022-10-11
- Inventor: Samantha Jane Bamford , Roger John Gillespie , Richard Simon Todd
- Applicant: Vernalis (R&D) Limited
- Applicant Address: GB Winnersh
- Assignee: Vernalis (R&D) Limited
- Current Assignee: Vernalis (R&D) Limited
- Current Assignee Address: GB Winnersh
- Agency: Foley & Lardner LLP
- Priority: GB0906579 20090416
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61K31/443 ; C07D487/04 ; A61K31/197 ; A61K45/06 ; C07D405/12
![Triazolo[4,5-d] pyramidine derivatives and their use as purine receptor antagonists](/abs-image/US/2022/10/11/US11466019B2/abs.jpg.150x150.jpg)
Abstract:
Compounds of formula (I) that are capable of acting as purine receptor antagonists, pharmaceutical compositions including the compounds, and methods of making the compounds, are disclosed. The compounds and compositions can be used in treating or preventing disorders related to purine receptor hyperfunctioning.
Public/Granted literature
- US20210115054A1 TRIAZOLO[4,5-D] PYRAMIDINE DERIVATIVES AND THEIR USE AS PURINE RECEPTOR ANTAGONISTS Public/Granted day:2021-04-22
Information query
IPC分类:
